
When 30-year U.S. Treasury yields touch 5.3%, the math behind every long-term investment gets rewired, and that can quietly reshuffle where risk and reward sit in your portfolio. Higher long-term rates can pressure some stocks while opening fresh angles for others that lean on investment income. This article explains how that backdrop relates to life insurers and annuity providers and highlights 3 stocks directly exposed to this rate story.
The three stocks covered next are a sample from a much wider field. The full screen also surfaced 8 more U.S. life insurers and annuity providers with equally compelling rate-sensitive narratives that are not discussed in this article. To see the broader opportunity set and refine it to your own risk and income preferences, head straight into the U.S. Life Insurers and Annuity Providers Benefiting from Higher Long-Term Yields screener
Overview: Everest Group is a global reinsurer and insurer that focuses on property and casualty coverage, writing business both through brokers and directly with other insurance companies. Its mix of long duration reinsurance and insurance liabilities, backed by large fixed income portfolios, gives it partial exposure to higher long term bond yields, even though broader property and casualty lines dilute this effect.
Operations: Everest Group generates most of its revenue from Reinsurance Treaty business at about $11.3b, alongside segment adjustments of roughly $3.4b and about $2.2b in unallocated net investment income, with a small decline recorded on unallocated net gains and losses on investments.
Market Cap: US$14.0b
Everest Group offers investors access to a large, globally diversified reinsurer with long duration insurance and reinsurance books that may be sensitive to changes in 30 year yields, while also relying on underwriting income. The company has been refining its portfolio, emphasizing underwriting discipline and specialty lines, and using tools such as the Annapurna Re sidecar to add capital flexibility. At the same time, there are analyst expectations of revenue pressure and there are governance and funding structure risks that could affect how much of any yield-related benefit reaches net income. Investors who prefer to gain exposure to higher long term rates through a diversified insurer rather than a pure life or annuity company may find Everest Group of interest for further research.
Everest Group’s mix of long duration reinsurance and underwriting discipline can make the headline story feel incomplete. To see how that blend shows up in the numbers around capital, liquidity and leverage, go through the Everest Group financial health report.
Everest Group and the two other stocks in this article all came from a single screen, but the real edge is setting filters that match how you think about risk, income and quality. Use our flexible Screener to combine metrics like valuation, balance sheet strength, risks and dividends, or tap into our curated Investing Ideas for ready-made shortlists.
Overview: Reinsurance Group of America is a global life and health reinsurer that takes on insurers’ long duration life, health and annuity style liabilities, including coinsurance of payout annuities, pension risk transfers and asset intensive reinsurance, in return for the investment and insurance profits those books can generate. It also offers underwriting and capital solutions such as funding agreement backed notes, longevity reinsurance and superannuation support, all built around helping primary insurers manage mortality, morbidity and investment related risks.
Operations: Reinsurance Group of America generates most of its revenue from U.S. and Latin America Traditional at about US$9.2b and Financial Solutions at about US$4.6b, with sizable contributions from Asia Pacific Traditional at about US$3.8b and Financial Solutions at about US$1.9b, and Europe, Middle East and Africa Traditional and Financial Solutions together at about US$4.3b.
Market Cap: US$16.0b
Reinsurance Group of America gives you direct exposure to the theme of higher long term yields feeding through into spread income on long dated life and annuity liabilities. It has a large U.S. and Latin America book and growing asset intensive deals that can benefit when new money rates move above the existing portfolio yield. At the same time, you are dealing with a complex balance sheet, earnings that can swing with claims and investment results, and external funding that ties performance closely to credit conditions. For investors willing to do the work on interest rate sensitivity, capital strength and claims volatility, RGA offers a detailed case study in how higher long end yields can support both reinvestment economics and dividend growth. However, the full picture around risks, competition and regional exposure sits beyond this short section.
Reinsurance Group of America sits where complex life books, asset intensive deals and long-term yields intersect, yet most investors only see the surface story. The 4 key rewards and 1 important warning sign could change how you read those moving parts
Overview: Citizens is a life insurer that collects long duration premiums from individuals and small businesses and invests those funds to back whole life, endowment, final expense and critical illness policies, so higher long term yields can directly influence its investment income and the economics of guaranteed products. Its Life Insurance segment focuses on U.S. dollar policies sold to non U.S. residents, while the Home Service Insurance segment provides final expense and related coverage through funeral homes and agents in U.S. regional markets.
Operations: Citizens generates most of its revenue from International Insurance at about US$173 million and Domestic Insurance at about US$81 million, with a very small contribution from Other Non Insurance Enterprises at about US$1 million.
Market Cap: US$192 million
Citizens provides relatively focused exposure to the idea that higher long term Treasury yields can influence a life insurer’s investment income and the value of long duration guarantees. Forecast earnings growth near 16% and a sizeable discount to estimated fair value suggest potential upside if management can translate that rate backdrop into steadier profitability, even with ROE projections still modest. At the same time, a P/E around 16.9x and forecast ROE near 4.7% highlight the risk that growth and capital efficiency may not fully align with expectations. With recent inclusion in Russell defensive and value defensive indices and a funding model that warrants close attention, Citizens represents a nuanced yield-linked story that may merit deeper research.
Citizens pairs forecast earnings growth near 16% with a modest forecast ROE around 4.7%, which raises a key question. The analyst forecasts for Citizens highlights how those projections could shift if one assumption breaks.
Markets move fast and the next breakout ideas rarely stay under the radar for long. Scan fresh momentum, catch dropping risks and find potential winners before the crowd arrives, then act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com